Originally, while entertaining a petition, the NGT on September 29 this year had told Sun Pharma to pay the interim compensation for operating and expanding its activity of drug manufacturing in bulk quantity at its Madhuranthagam facility without a valid environmental clearance.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZDrcM3Y
via IFTTT
0 comments:
Post a Comment